# Ideal Power Inc.: Form 10-Q for the period ended Jun 30, 2020

- Company: [Ideal Power Inc.](/companies/ipwr.md) (CIK 1507957)
- Form: 10-Q
- Filed: 2020-08-13
- Accepted by EDGAR: Aug 13, 2020, 16:16 ET
- Period: 2020-06-30
- Accession: 0001104659-20-094683
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1507957/000110465920094683/tm2020412-1_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1507957/000110465920094683/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-04-01 to 2020-06-30 | $6.5k | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months, 2020-01-01 to 2020-06-30 | $6.5k | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2020-04-01 to 2020-06-30 | $6.5k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2020-01-01 to 2020-06-30 | $6.5k | us-gaap:CostOfRevenue |
| Research and development | 3 months, 2020-04-01 to 2020-06-30 | $316.3k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2020-01-01 to 2020-06-30 | $667.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2020-04-01 to 2020-06-30 | −$832.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-01-01 to 2020-06-30 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2020-04-01 to 2020-06-30 | −$833.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2020-01-01 to 2020-06-30 | −$1.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-04-01 to 2020-06-30 | −$0.28 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2020-01-01 to 2020-06-30 | −$0.59 | us-gaap:EarningsPerShareBasicAndDiluted |
| Capital expenditure | 6 months, 2020-01-01 to 2020-06-30 | $10.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-06-30 | $1.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-06-30 | $2.0m | us-gaap:AssetsCurrent |
| Total assets | at 2020-06-30 | $3.8m | us-gaap:Assets |
| Current liabilities | at 2020-06-30 | $551.6k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-06-30 | $1.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-06-30 | $2.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,337 characters.

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q as well as our audited 2019 financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2019. In addition to historical information, the discussion and analysis here and throughout this Form 10-Q contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited, to those set forth under “Risk Factors” in Part II, Item 1A of this report.*

### Overview

Ideal Power Inc. is located in Austin, Texas. Until April 2018, we were primarily focused on the design, marketing and sale of electrical power conversion products using our proprietary technology called Power Packet Switching Architecture™, or PPSA™. PPSA™ is a power conversion technology that improves upon existing power conversion technologies in key product metrics, such as size and weight while providing built-in isolation and bi-directional and multi-port capabilities. PPSA™ utilizes standardized hardware with application specific embedded software. Our products were designed to be used in both on-grid and off-grid applications with a focus on solar + storage, microgrid and stand-alone energy storage applications. The principal products of the Company were 30-kilowatt power conversion systems, including 2-port and multi-port products.

In April 2018, we realigned into two operating divisions: Power Conversion Systems, to continue the commercialization of our PPSA™ technology, and B-TRAN, to develop our Bi-directional bi-polar junction TRANsistor (B-TRAN™) solid state switch technology.

In January 2019, our Board of Directors approved a strategic shift to focus on the commercialization of our B-TRAN™ technology and a plan to suspend further power converter system, or PPSA™, development and sales while we located a buyer for our power conversion systems division and PPSA™ technology. In September 2019, we closed on the sale of our power conversion systems division and are now solely focused on the further development and commercialization of our B-TRAN™ technology. Prior to the sale of our PPSA™ business and technology in September 2019, we classified this division as held for sale. We show this division as a discontinued operation in our financial statements.

To date, operations have been funded primarily through the sale of common stock and warrants. Total revenue generated from inception to date as of June 30, 2020 amounted to $14.9 million with approximately $12.4 million of that revenue from discontinued operations and the remainder from grant revenue for bi-directional power switch development. Grant revenue was $6,515 for the three and six months ended June 30, 2020. We did not have revenue from continuing operations in the three and six months ended June 30, 2019. We may pursue additional research and development grants, if and when available, to further develop and/or improve our technology.

#### COVID-19 Impact

In March 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to spread throughout the United States and the rest of the world. The ultimate extent of the impact of COVID-19 on the financial performance of the Company will depend on future developments, including, among other things, the duration and spread of COVID-19, and the overall economy, all of which are highly uncertain and cannot be predicted. The outbreak of COVID-19 has already caused significant disruptions to the global financial markets which may impact the Company’s ability to raise additional capital, on acceptable terms or at all. If the financial markets and/or the overall economy are impacted for an extended period, the Company's operating results may be materially and adversely affected.

### Results of Operations

### Comparison of the three months ended June 30, 2020 to the three months ended June 30, 2019

*Grant Revenues.* Grant revenues for the three months ended June 30, 2020 were $6,515. The grant revenues relate to a $1.2 million subcontract with Diversified Technologies, Inc. (DTI) to supply B-TRAN™ devices as part of a two-year contract awarded to DTI by the United States Naval Sea Systems Command (NAVSEA) for the development and demonstration of a B-TRAN™ enabled high efficiency direct current circuit breaker.

*Cost of Grant Revenues.* Cost of grant revenues for the three months ended June 30, 2020 was $6,515. The cost of grant revenues relates to the subcontract discussed above and are equal to the associated grant revenues resulting in no gross profit.

*Research and Development Expenses.* Research and development expenses decreased by $19,427, or 6%, to $316,325 in the three months ended June 30, 2020 from $335,752 in the three months ended June 30, 2019. The decrease was due to lower stock compensation expense of $46,923, facilities costs of $24,592 and other B-TRAN™ development spending of $14,793, partly offset by higher bonus expense of $66,881.

*General and Administrative Expenses.* General and administrative expenses decreased by $64,785, or 11%, to $515,878 in the three months ended June 30, 2020 from $580,663 in the three months ended June 30, 2019. The decrease was due to lower legal fees of $120,236 and facilities costs of $40,398, partly offset by higher stock compensation expense of $43,025, bonus expense of $23,653, Board of Director fees of $15,564 and other costs of $13,607.

*Interest Expense, Net.* Net interest expense was $1,055 for the three months ended June 30, 2020 compared to net interest income of $6,809 for the three months ended June 30, 2019.

*Loss from Continuing Operations.* Our loss from continuing operations for the three months ended June 30, 2020 was $833,258 or 8% lower than the $909,606 loss from continuing operations for the three months ended June 30, 2019 due to the reduction in general and administrative expenses and research and development expenses discussed above.

*Loss from Discontinued Operations.* Our loss from discontinued operations for the three months ended June 30, 2019 was $342,076 and included a $265,000 impairment of assets held for sale. As we sold our power conversion systems division in September 2019, we did not have a loss from discontinued operations for the three months ended June 30, 2020.

*Net Loss.* Our net loss for the three months ended June 30, 2020 was $833,258, or 33% lower, as compared to a net loss of $1,251,682 for the three months ended June 30, 2019, for the reasons discussed above.

### Comparison of the six months ended June 30, 2020 to the six months ended June 30, 2019

*Grant Revenues.* Grant revenues for the six months ended June 30, 2020 were $6,515. The grant revenues relate to a $1.2 million subcontract with DTI to supply B-TRAN™ devices as part of a two-year contract awarded to DTI by NAVSEA for the development and demonstration of a B-TRAN™ enabled high efficiency direct current circuit breaker.

*Cost of Grant Revenues.* Cost of grant revenues for the six months ended June 30, 2020 was $6,515. The cost of grant revenues relates to the subcontract discussed above and are equal to the associated grant revenues resulting in no gross profit. We expect no gross profit under the subcontract with DTI.

*Research and Development Expenses.* Research and development expenses increased by $113,021, or 20%, to $666,989 in the six months ended June 30, 2020 from $553,968 in the six months ended June 30, 2019. The increase was due primarily to higher semiconductor fabrication costs of $95,453 and bonus expense of $67,013, partly offset by lower facilities costs of $39,485. We expect flat to modestly higher research and development expenses for the remainder of 2020, although these expenses will be subject to quarterly variability due primarily to the timing of semiconductor fabrication costs.

*General and Administrative Expenses.* General and administrative expenses increased by $46,595, or 4%, to $1,095,648 in the six months ended June 30, 2020 from $1,049,053 in the six months ended June 30, 2019. The increase was primarily due to fees incurred in connection with the search for our new chief executive officer of $137,459 and higher stock compensation expense of $93,858 and bonus expense of $23,681, partly offset by lower legal fees of $141,450 and facilities costs of $62,737. We expect relatively flat general and administrative expenses for the remainder of 2020, exclusive of potentially incremental bonus expense upon the achievement of certain performance goals by executives.

*Interest Expense, Net.* Net interest expense was $1,122 for the six months ended June 30, 2020 compared to $309 for the six months ended June 30, 2019.

*Loss from Continuing Operations.* Our loss from continuing operations for the six months ended June 30, 2020 was $1,763,759 or 10% higher than the $1,603,330 loss from continuing operations for the six months ended June 30, 2019 due to the increase in research and development expenses and general and administrative expenses discussed above.

*Loss from Discontinued Operations.* Our loss from discontinued operations for the six months ended June 30, 2019 was $689,251 and included a $405,000 impairment of assets held for sale. As we sold our power conversion systems division in September 2019, we did not have a loss from discontinued operations for the six months ended June 30, 2020.

*Net Loss.* Our net loss for the six months ended June 30, 2020 was $1,763,759, or 23% lower, as compared to a net loss of $2,292,581 for the six months ended June 30, 2019, for the reasons discussed above.

### Liquidity and Capital Resources

We currently generate minimal grant revenue only. We have funded our operations through the sale of common stock and warrants.

At June 30, 2020, we had cash and cash equivalents of $1,793,582 and net working capital of $1,465,770.

Our long-term debt at June 30, 2020 was $96,407. As discussed below, in May 2020, we received a PPP Loan (as defined below) of $91,407 to temporarily subsidize our payroll and facilities costs in a business landscape impacted by the COVID-19 pandemic. We also received a $5,000 advance related to a U.S. Small Business Administration Economic Injury Disaster Loan in April 2020.

Operating activities in the six months ended June 30, 2020 resulted in cash outflows of $1,502,357, which were due to the loss from continuing operations for the period of $1,763,759 and unfavorable balance sheet timing of $90,249 partly offset by stock-based compensation of $226,168, depreciation and amortization of $57,248, stock issued for services of $50,000 and patent impairment charges of $18,235. Operating activities in the six months ended June 30, 2019 resulted in cash outflows of $1,764,376, which were due to the loss from continuing operations for the period of $1,603,330 and cash used in operating activities related to discontinued operations of $465,238 partly offset by non-cash items, including depreciation and amortization and stock-based compensation, of $196,687 and favorable balance sheet timing of $107,595. We expect relatively flat cash outflows from operating activities for the remainder of 2020, although these outflows will be subject to quarterly variability due primarily to the timing of research and development expenditures.

Investing activities in the six months ended June 30, 2020 and 2019 resulted in cash outflows of $33,966 and $55,904, respectively, for the acquisition of intangible assets and fixed assets.

Financing activities in the six months ended June 30, 2020 resulted in cash inflows of $272,223 and included net proceeds from the exercise of warrants of $175,816 and proceeds from loans of $96,407. For the six months ended June 30, 2019, financing activities resulted in no cash inflows or outflows.

The Company’s cash and cash equivalent balance at June 30, 2020 relative to its estimate of future operating cash requirements led to substantial doubt about the ability of the Company to continue as a going concern. The Company’s independent registered public accounting firm, in its report on the Company’s 2019 financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. On August 5, 2020 the Company completed an early warrant exercise transaction, described below, raising estimated net proceeds of $2.5 million, thereby alleviating the substantial doubt about the Company’s ability to continue as a going concern for at least the next twelve months from the date of issuance of this Form 10-Q.

As our B-TRAN™ technology is in the development stage and has not yet been commercialized, we may be required to obtain additional financing to continue our operations and execute our business plan. We may not be able to obtain such financing on commercially reasonable terms or at all, especially in light of the market volatility and uncertainty as a result of the COVID-19 outbreak. If we are unable to obtain such financing if and when needed, we will be required to reduce operating costs, which could jeopardize future strategic initiatives and business plans, or cease operations. In addition, there can be no assurances that we will be able to successfully commercialize our technology and develop profitable operations.

#### PPP Loan

On May 4, 2020, we entered into a Loan Agreement and Promissory Note (collectively the “PPP Loan”) with BBVA USA pursuant to the Paycheck Protection Program (the “PPP”) under the recently enacted Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) administered by the U.S. Small Business Administration. We received total proceeds of $91,407 from the unsecured PPP Loan. The PPP Loan is scheduled to mature on May 4, 2022 and has an interest rate of 1.00% per annum and is subject to the terms and conditions applicable to loans administered by the U.S. Small Business Administration under the CARES Act. The PPP Loan may be prepaid by us at any time prior to its maturity with no prepayment penalties.

The PPP Loan contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. Subject to certain conditions, the PPP Loan may be forgiven in whole or in part by applying for forgiveness pursuant to the CARES Act and the PPP. The amount of loan proceeds eligible for forgiveness is based on a formula based on a number of factors, including the amount of loan proceeds used by us during the 24-week period after the loan origination for certain purposes, including payroll costs, rent payments on certain leases, and certain qualified utility payments, provided that, among other things, at least 60% of the loan amount is used for eligible payroll costs, the employer maintaining or rehiring employees and maintaining salaries at certain level. In accordance with the requirements of the CARES Act and the PPP, we used the proceeds from the PPP Loan primarily for payroll costs. We intend to apply for forgiveness of the PPL Loan during the third quarter of 2020. It is our expectation that the PPP Loan will be forgiven but no assurance can be given that we will be granted forgiveness of the PPP Loan in whole or in part.

#### Private Placement

On November 13, 2019, we closed on a private placement of our common stock and warrants to purchase common stock for aggregate gross proceeds of $3.5 million and net proceeds of $3.1 million. We have been utilizing, and expect to continue to utilize, the net proceeds from this private placement to fund commercialization and development of our B-TRAN™ semiconductor technology and for working capital and general corporate purposes.

#### Early Warrant Exercise Transaction

On July 31, 2020, we entered into letter agreements (the “Letter Agreements”) with certain of our Series A warrant holders (the “Series A Warrant Holders”), who were previously issued warrants (the “Original Warrants”) to purchase shares of our common stock pursuant to that certain securities purchase agreement between us and the other parties thereto, dated as of November 7, 2019. The Series A Warrant Holders agreed to the early exercise of their Original Warrants pursuant to the Letter Agreements (the “Transaction”). The Transaction closed on August 5, 2020. We raised estimated net proceeds of approximately $2.5 million in the Transaction. We intend to utilize the net proceeds from the Transaction to fund commercialization and development of our B-TRAN™ semiconductor technology and general corporate and working capital purposes.

Pursuant to the Letter Agreements, in consideration of the Series A Warrant Holders exercising Original Warrants to purchase an aggregate of 1,176,137 shares of common stock, we issued to the Series A Warrant Holders new Series C warrants (the “New Warrants”) to purchase up to an aggregate of 705,688 shares of common stock, which is equal to 60% of the shares underlying the Original Warrants included in the Transaction. The New Warrants have an exercise price of $8.90 per share and an expiration date of August 4, 2025.

### Critical Accounting Policies

#### Revenue Recognition

We recognize revenue and related cost of revenue in accordance with FASB ASC 606, *Revenue from Contracts with Customers* (ASC 606) and, as applicable, with the guidance issued by the FASB in June 2018 for the recipients of grants.

Currently, we recognize grant revenue and cost of grant revenue only. Government contracts, including grants, are agreements that generally provide us with cost reimbursement for certain types of development activities over a contractually defined period. Grant revenue is recognized in the period during which we incur the related costs, provided that we have incurred the cost in accordance with the specifications and work plans determined between us and the government entity.

For the six months ended June 30, 2020, we recognized $6,515 of grant revenue and cost of grant revenue. The grant revenue relates to a $1.2 million subcontract with Diversified Technologies, Inc. (DTI), signed in June 2020, to supply B-TRAN™ devices as part of a two-year contract awarded to DTI by the United States Naval Sea Systems Command (NAVSEA) for the development and demonstration of a B-TRAN™ enabled high efficiency direct current circuit breaker. We account for this subcontract as an exchange transaction under applicable guidance. No grant revenue was recognized in the six months ended June 30, 2019. Unbilled grant receivables were $6,515 at June 30, 2020 and were included in prepayments and other current assets on our balance sheet.

There have been no other significant changes during the six months ended June 30, 2020 to the critical accounting policies disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

### Off-Balance Sheet Transactions

As of June 30, 2020, we did not have any off-balance sheet transactions.

## Controls and procedures

As filed, 2,961 characters.

### Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the Company’s reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. The Company’s disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that this information is accumulated and communicated to management, including the principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company conducted an evaluation (pursuant to Rule 13a-15(b) of the Exchange Act), under the supervision and with the participation of its Chief Executive Officer (principal executive officer) and its Chief Financial Officer (principal financial and accounting officer) of the effectiveness of the Company’s disclosure controls and procedures as of June 30, 2020 and has concluded that, as of June 30, 2020, the Company’s disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There have been no material changes in our internal controls over financial reporting that occurred during the quarter ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

### Limitations on the Effectiveness of Controls

Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any system of controls must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

Filed Aug 13, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-094683. Last ingested by Listed: Nov 12, 2026, 19:54 ET. No prices; not investment advice.
